These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 23276668)

  • 1. Comparative efficacy of 3 soluble epoxide hydrolase inhibitors in rat neuropathic and inflammatory pain models.
    Wagner K; Inceoglu B; Dong H; Yang J; Hwang SH; Jones P; Morisseau C; Hammock BD
    Eur J Pharmacol; 2013 Jan; 700(1-3):93-101. PubMed ID: 23276668
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Soluble epoxide hydrolase inhibition is antinociceptive in a mouse model of diabetic neuropathy.
    Wagner K; Yang J; Inceoglu B; Hammock BD
    J Pain; 2014 Sep; 15(9):907-14. PubMed ID: 24924124
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preparation and evaluation of soluble epoxide hydrolase inhibitors with improved physical properties and potencies for treating diabetic neuropathic pain.
    Lee KSS; Ng JC; Yang J; Hwang SH; Morisseau C; Wagner K; Hammock BD
    Bioorg Med Chem; 2020 Nov; 28(22):115735. PubMed ID: 33007552
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Soluble epoxide hydrolase inhibition alleviates neuropathy in Akita (Ins2 Akita) mice.
    Wagner K; Gilda J; Yang J; Wan D; Morisseau C; Gomes AV; Hammock BD
    Behav Brain Res; 2017 May; 326():69-76. PubMed ID: 28259677
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Optimized inhibitors of soluble epoxide hydrolase improve in vitro target residence time and in vivo efficacy.
    Lee KS; Liu JY; Wagner KM; Pakhomova S; Dong H; Morisseau C; Fu SH; Yang J; Wang P; Ulu A; Mate CA; Nguyen LV; Hwang SH; Edin ML; Mara AA; Wulff H; Newcomer ME; Zeldin DC; Hammock BD
    J Med Chem; 2014 Aug; 57(16):7016-30. PubMed ID: 25079952
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oral treatment of rodents with soluble epoxide hydrolase inhibitor 1-(1-propanoylpiperidin-4-yl)-3-[4-(trifluoromethoxy)phenyl]urea (TPPU): Resulting drug levels and modulation of oxylipin pattern.
    Ostermann AI; Herbers J; Willenberg I; Chen R; Hwang SH; Greite R; Morisseau C; Gueler F; Hammock BD; Schebb NH
    Prostaglandins Other Lipid Mediat; 2015 Sep; 121(Pt A):131-7. PubMed ID: 26117215
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Meloxicam fails to augment the reno-protective effects of soluble epoxide hydrolase inhibition in streptozotocin-induced diabetic rats via increased 20-HETE levels.
    Katary MM; Pye C; Elmarakby AA
    Prostaglandins Other Lipid Mediat; 2017 Sep; 132():3-11. PubMed ID: 27596333
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of soluble epoxide hydrolase reduces LPS-induced thermal hyperalgesia and mechanical allodynia in a rat model of inflammatory pain.
    Inceoglu B; Jinks SL; Schmelzer KR; Waite T; Kim IH; Hammock BD
    Life Sci; 2006 Nov; 79(24):2311-9. PubMed ID: 16962614
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Small Molecule Soluble Epoxide Hydrolase Inhibitors in Multitarget and Combination Therapies for Inflammation and Cancer.
    Das Mahapatra A; Choubey R; Datta B
    Molecules; 2020 Nov; 25(23):. PubMed ID: 33255197
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Soluble epoxide hydrolase inhibition, epoxygenated fatty acids and nociception.
    Wagner K; Inceoglu B; Hammock BD
    Prostaglandins Other Lipid Mediat; 2011 Nov; 96(1-4):76-83. PubMed ID: 21854866
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discovery of Potent Soluble Epoxide Hydrolase (sEH) Inhibitors by Pharmacophore-Based Virtual Screening.
    Waltenberger B; Garscha U; Temml V; Liers J; Werz O; Schuster D; Stuppner H
    J Chem Inf Model; 2016 Apr; 56(4):747-62. PubMed ID: 26882208
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A multimodal disease modifying approach to treat neuropathic pain--inhibition of soluble epoxide hydrolase (sEH).
    Pillarisetti S; Khanna I
    Drug Discov Today; 2015 Nov; 20(11):1382-90. PubMed ID: 26259523
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peripheral FAAH and soluble epoxide hydrolase inhibitors are synergistically antinociceptive.
    Sasso O; Wagner K; Morisseau C; Inceoglu B; Hammock BD; Piomelli D
    Pharmacol Res; 2015 Jul; 97():7-15. PubMed ID: 25882247
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Further exploration of the structure-activity relationship of dual soluble epoxide hydrolase/fatty acid amide hydrolase inhibitors.
    Wilt S; Kodani S; Valencia L; Hudson PK; Sanchez S; Quintana T; Morisseau C; Hammock BD; Kandasamy R; Pecic S
    Bioorg Med Chem; 2021 Dec; 51():116507. PubMed ID: 34794001
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endoplasmic reticulum stress in the peripheral nervous system is a significant driver of neuropathic pain.
    Inceoglu B; Bettaieb A; Trindade da Silva CA; Lee KS; Haj FG; Hammock BD
    Proc Natl Acad Sci U S A; 2015 Jul; 112(29):9082-7. PubMed ID: 26150506
    [TBL] [Abstract][Full Text] [Related]  

  • 16. EETs/sEHi alleviates nociception by blocking the crosslink between endoplasmic reticulum stress and neuroinflammation in a central poststroke pain model.
    Liu T; Li T; Chen X; Li Z; Feng M; Yao W; Wan L; Zhang C; Zhang Y
    J Neuroinflammation; 2021 Sep; 18(1):211. PubMed ID: 34530836
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of soluble epoxide hydrolase by fulvestrant and sulfoxides.
    Morisseau C; Pakhomova S; Hwang SH; Newcomer ME; Hammock BD
    Bioorg Med Chem Lett; 2013 Jul; 23(13):3818-21. PubMed ID: 23684894
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gene deficiency and pharmacological inhibition of soluble epoxide hydrolase confers resilience to repeated social defeat stress.
    Ren Q; Ma M; Ishima T; Morisseau C; Yang J; Wagner KM; Zhang JC; Yang C; Yao W; Dong C; Han M; Hammock BD; Hashimoto K
    Proc Natl Acad Sci U S A; 2016 Mar; 113(13):E1944-52. PubMed ID: 26976569
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epoxygenated fatty acids and soluble epoxide hydrolase inhibition: novel mediators of pain reduction.
    Wagner K; Inceoglu B; Gill SS; Hammock BD
    J Agric Food Chem; 2011 Apr; 59(7):2816-24. PubMed ID: 20958046
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Soluble epoxide hydrolase in rat inflammatory cells is indistinguishable from soluble epoxide hydrolase in rat liver.
    Draper AJ; Hammock BD
    Toxicol Sci; 1999 Jul; 50(1):30-5. PubMed ID: 10445750
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.